Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
Ashley M. Henneghan(The University of Texas at Austin), Shelli R. Kesler(The University of Texas at Austin), Eliana R Gill(Seton Medical Center Austin), Kimberly Lewis(Impact)
Cited by 87
Related Papers
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
|Intensive Care Medicine|2021|302
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
|JNCI Journal of the National Cancer Institute|2021|115
Disrupted brain network functional dynamics and hyper‐correlation of structural and functional connectome topology in patients with breast cancer prior to treatment
|Brain and Behavior|2017|78
Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review
|Supportive Care in Cancer|2015|62
Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors
|Biological Research For Nursing|2019|47